Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Beta Pharma To Manufacture Sunshine Drug | Contract Pharma

What are you searching for?

Sign in
Breaking News

Beta Pharma To Manufacture Sunshine Drug

To provide synthesis parameters for scale-up and large scale manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sunshine Biopharma, Inc. has contracted Beta Pharma Canada, Inc. to manufacture an initial batch of its Adva-27a cancer drug and provide synthesis parameters for future scale-up and large scale manufacturing of the drug.
 
Beta Pharma Canada, Inc., headquartered in Montreal, is an affiliate of Beta Pharma, Inc. with offices and facilities in Connecticut and Shanghai. Adva-27a is Sunshine’s lead anti-cancer compound, which has been proven effective in killing Multidrug Resistant Breast Cancer cells (MCF-7/MDR) and Small-Cell Lung Cancer cells (H69AR).
 
“We are delighted to be working with Beta Pharma Canada with excellent in-house synthesis capability and can amass additional resources through its corporate affiliations,” said Dr. Steve N. Slilaty, Sunshine’s president and chief executive officer. “We anticipate delivery of the new batch of Adva-27a together with the synthesis parameters by the end of the month.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters